NCCN 7th Annual Congress: Hematologic Malignancies™

New York, NY US
September 14, 2012 to September 15, 2012

The treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of new advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients.

This 2-day congress will focus on the most up-to-date treatment recommendations, important issues, controversies, recent scientific findings, and future directions for hematologic malignancies. The agenda includes presentations on myelodisplastic syndromes, multiple myeloma, chronic myelogenous leukemia, acute lymphoblastic leukemia, lymphomas, transplantation, and supportive care topics including management of anemia, treatment of venous thromboembolic disease, and management of idiopathic thrombocytopenic purpura.

Target Audience

This congress is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.

Additional information
Supporters: 

This congress is supported by an educational donation provided by:

  • Amgen

This congress is supported by educational grants from:

  • Abbott
  • ARIAD Pharmaceuticals, Inc.
  • Astellas Scientific and Medical Affairs, Inc.
  • Bristol-Myers Squibb
  • Celgene Corporation
  • Genentech
  • Millennium: The Takeda Oncology Company
  • Novartis Pharmaceuticals Corporation
  • Onyx Pharmaceuticals, Inc.
  • Otsuka America Pharmaceutical, Inc.
  • Pfizer
  • sanofi-aventis U.S.
  • Seattle Genetics, Inc.
  • Sigma-Tau Pharmaceuticals, Inc.
  • Spectrum Pharmaceuticals, Inc.
  • Sunesis Pharmaceuticals


The National Comprehensive Cancer Network® (NCCN®) appreciates that supporting companies recognize NCCN®’s need for autonomy in the development of the content of NCCN® resources. All NCCN content is produced completely independently.

This list reflects supporters as of August 27, 2012.

Course summary
Available credit: 
  • 11.25 Participation
  • 9.90 Nurse
  • 11.25 Pharmacist
  • 11.25 Physician
Course opens: 
09/14/2012
Course expires: 
01/31/2013
Event starts: 
09/14/2012 - 8:00am
Event ends: 
09/15/2012 - 12:30pm
Cost:
$0.00
New York Marriott Marquis
1535 Broadway
(Broadway Ballroom - 6th floor)
New York, NY 10036
United States

Available Credit

  • 11.25 Participation
  • 9.90 Nurse
  • 11.25 Pharmacist
  • 11.25 Physician

Accreditation Period

Course opens: 
09/14/2012
Course expires: 
01/31/2013

Price

Cost:
$0.00
Please login or register to take this course.